Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Covington
Baxter
Federal Trade Commission
Novartis
McKesson
Moodys
Fuji
QuintilesIMS
Teva

Generated: August 16, 2017

DrugPatentWatch Database Preview

Losartan potassium - Generic Drug Details

« Back to Dashboard

What are the generic sources for losartan potassium and what is the scope of losartan potassium freedom to operate?

Losartan potassium
is the generic ingredient in two branded drugs marketed by Sandoz, Alembic Pharms Ltd, Watson Labs, Macleods Pharms Ltd, Unichem Labs Ltd, Lupin Ltd, Hetero Labs Ltd V, Micro Labs Ltd India, Zydus Pharms Usa Inc, Upsher-smith Labs, Teva, West-ward Pharms Int, Torrent Pharms, Cadista Pharms, Vivimed Labs, Aurobindo Pharma, Merck Sharp Dohme, Apotex Corp, Ipca Labs Ltd, Mylan, and Prinston Inc, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-seven drug master file entries for losartan potassium. Sixty-nine suppliers are listed for this compound.

Summary for Generic Name: losartan potassium

Tradenames:2
Patents:0
Applicants:21
NDAs:21
Drug Master File Entries: see list37
Suppliers / Packagers: see list69
Bulk Api Vendors: see list142
Clinical Trials: see list811
Patent Applications: see list4,778
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:losartan potassium at DailyMed

Pharmacology for Ingredient: losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL077459-003Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL076958-002Apr 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Vivimed Labs
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL090382-002Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Micro Labs Ltd India
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL091541-003Sep 24, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL078232-003Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
COZAAR
losartan potassium
TABLET;ORAL020386-002Apr 14, 1995► Subscribe► Subscribe
Merck Sharp Dohme
COZAAR
losartan potassium
TABLET;ORAL020386-003Oct 13, 1998► Subscribe► Subscribe
Merck Sharp Dohme
COZAAR
losartan potassium
TABLET;ORAL020386-001Apr 14, 1995► Subscribe► Subscribe
Merck Sharp Dohme
COZAAR
losartan potassium
TABLET;ORAL020386-003Oct 13, 1998► Subscribe► Subscribe
Merck Sharp Dohme
COZAAR
losartan potassium
TABLET;ORAL020386-002Apr 14, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Covington
Farmers Insurance
Cantor Fitzgerald
Fish and Richardson
McKesson
Citi
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot